3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
10
Leukemia, Myeloid, Acute
10
Multiple Myeloma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Non-Hodgkin
5
Hodgkin Disease
4
Recurrence
3
Myeloproliferative Disorders
3
Anemia, Refractory, with Excess of Blasts
3
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Graft vs Host Disease
2
Ganglioneuroblastoma
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Interventions
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
×
Melphalan
×
30 days
×
Clear all
No trials found.